These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6140616)

  • 81. [Indications and results of surgical treatment of ulcers. Considerations after the introduction of H2-receptor antagonists].
    Barner S; Waldmann D; Farthmann EH
    Fortschr Med; 1984 Jul; 102(25-26):692-6. PubMed ID: 6147305
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Impact of ranitidine on prognosis after simple closure of perforated duodenal ulcer.
    Singh K; Chhina RS; Ghosh A; Kaura R
    Trop Gastroenterol; 1999; 20(2):90-2. PubMed ID: 10484900
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Pharmacology and clinical effects of acid determination in ulcer hemorrhage].
    Schepp W
    Bildgebung; 1993 Apr; 60 Suppl 1():41-4. PubMed ID: 8104063
    [No Abstract]   [Full Text] [Related]  

  • 84. [Gastric emptying in patients with duodenal peptic ulcer before and after H2 blockader therapy].
    Usai P; Piga M; Satta L; Vincis R; Loi G; Balestrieri A
    Minerva Dietol Gastroenterol; 1985; 31(2):113-6. PubMed ID: 4034015
    [No Abstract]   [Full Text] [Related]  

  • 85. Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats.
    Sekiguchi H; Hamada K; Aijima H; Taga F; Uchida H; Nishino K
    Arzneimittelforschung; 1993 Feb; 43(2):139-43. PubMed ID: 8096134
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
    Lanas Arbeloa A; Serrano Aulló MT
    Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():20-4. PubMed ID: 9549198
    [No Abstract]   [Full Text] [Related]  

  • 87. [Acid secretory rebound after gastric antisecretory treatment. Above all, a problem for the physiologists!].
    Vallot T; Mignon M
    Gastroenterol Clin Biol; 1994; 18(8-9):677-9. PubMed ID: 7875433
    [No Abstract]   [Full Text] [Related]  

  • 88. Giant gastric ulcer: its natural history and outcome in the H2RA era.
    Raju GS; Bardhan KD; Royston C; Beresford J
    Am J Gastroenterol; 1999 Dec; 94(12):3478-86. PubMed ID: 10606307
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Duodenal ulcer: an update.
    Wormsley KG
    Mt Sinai J Med; 1981; 48(5):391-6. PubMed ID: 6117792
    [No Abstract]   [Full Text] [Related]  

  • 90. Ranitidine: a new H2-receptor antagonist.
    Berner BD; Conner CS; Sawyer DR; Siepler JK
    Clin Pharm; 1982; 1(6):499-509. PubMed ID: 6309467
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Suppression of gastric acidity in horses.
    Murray MJ
    J Am Vet Med Assoc; 1997 Jul; 211(1):37-40. PubMed ID: 9215408
    [No Abstract]   [Full Text] [Related]  

  • 92. [H2 blockers in the treatment of bleeding gastroduodenal ulcers].
    Nikiforov PA; Bazarova MA; Nikitina SA; Osin VL; Shugurov VA
    Khirurgiia (Mosk); 2001; (10):49-50. PubMed ID: 11763821
    [No Abstract]   [Full Text] [Related]  

  • 93. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [The role of surgery in the comparison of peptic ulcer before and after the advent of H2 receptor blockers in the light of our experience].
    Pinto E; Verre L; De Stefano A; Trombì G
    Minerva Chir; 1987 Sep; 42(18):1375-82. PubMed ID: 2892149
    [No Abstract]   [Full Text] [Related]  

  • 95. Acid peptic disease in relation to Ramadan fasting: a preliminary endoscopic evaluation.
    Mallk GM; Mubarik M; Hussain T
    Am J Gastroenterol; 1995 Nov; 90(11):2076-7. PubMed ID: 7485044
    [No Abstract]   [Full Text] [Related]  

  • 96. Clinical perspectives of drugs inhibiting acid secretion: histamine H2 antagonists.
    Bauerfeind P; Popien J; Traber M; Bumm R; Cucala M; Dorta G; Blum AL
    Scand J Gastroenterol Suppl; 1986; 125():42-9. PubMed ID: 2881346
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Nocturnal gastric secretion and duodenal ulcer].
    Mazure RM; Mazure PA
    Acta Gastroenterol Latinoam; 1984; 14(3):243-8. PubMed ID: 6152644
    [No Abstract]   [Full Text] [Related]  

  • 98. [The endoscopic assessment of the effect of ranitidine and pirenzepine on the manifestations of the gastropathy induced by nonsteroidal anti-inflammatory preparations].
    Karateev AE; Murav'ev IuV; Nasonova VA
    Ter Arkh; 1997; 69(5):67-9. PubMed ID: 9235663
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T; Lemaire M; Agostini H
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.